Raymond James lowers Atlas Crest Investment stock price target to $14 from $15

Published 11/08/2025, 11:36
Raymond James lowers Atlas Crest Investment stock price target to $14 from $15

Investing.com - Raymond (NSE:RYMD) James lowered the price target on Atlas Crest Investment Corp (NASDAQ:ACIC) to $14.00 from $15.00 while maintaining an Outperform rating. The stock, currently trading at $10.24, shows strong fundamentals with a "GREAT" Financial Health Score according to InvestingPro data.

The price target reduction is based on the stock trading at approximately 10 times Raymond James’ 2026 operating EPS estimate. With a current P/E ratio of 6.24 and impressive revenue growth of 33.9% in the last twelve months, detailed analysis available in the comprehensive Pro Research Report suggests the stock may be undervalued relative to its growth potential.

Raymond James noted that Atlas Crest Investment stock is currently trading at approximately 7 times their 2026 operating EPS estimate, compared to the total peer average of about 10 times.

The firm believes a premium to Florida property peers (approximately 8 times) and a discount to specialty insurers (approximately 12 times) is justified for Atlas Crest Investment.

This valuation perspective is supported by Raymond James’ outlook for above-peer average operating ROBEs, leading underwriting results, and the company’s concentration in Florida property.

In other recent news, American Coastal Insurance Corporation reported strong financial results for the second quarter of 2025. The company experienced significant year-over-year growth in both net income and revenues. This performance highlights American Coastal Insurance’s continued expansion in the Florida property insurance market. Despite facing a challenging environment, the company managed to maintain a stable position, reflecting investor confidence. These developments are part of the company’s strategic direction to solidify its market presence. The recent earnings call emphasized the firm’s robust financial health and growth trajectory. Investors might find these results encouraging as they consider the company’s future potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.